tDCS for Post-Stroke Cognitive Impairment
Recruiting now · Phase 2 · Has a placebo group
Conditions studied: Stroke, Mild Cognitive Impairment
In brief
This study will evaluate the effects of a form of non-invasive brain stimulation on brain functioning and memory in participants with post-stroke cognitive impairment (PSCI).
Key facts
- Study ID
- NCT06516588
- Run by
- University of Oklahoma
- People needed
- 80
- Starts
- 2024-09-30
- Expected to finish
- 2027-06-30
- Last updated by the study team
- 2024-10-10
Who can join
Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- ischemic stroke participants in sub-acute phase (at least 10 days after stroke event or discharge and under 5 months post-event) with cognitive dysfunction (MoCA <26);
You may not qualify if…
- clinically significant or unstable medical or psychiatric condition;
- diagnosis of severe depression;
- history of relevant neurological diagnosis (e.g., epilepsy);
- previous neurosurgical procedure with craniectomy;
- contraindications to tDCS (implanted brain medical devices);
- severe visual impairment, hearing impairment, aphasia, neglect or dementia.
Where it is running
- University of Oklahoma — Oklahoma City, Oklahoma, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.